NASDAQ:AMTX - Aemetis Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.21 +0.01 (+0.83 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$1.21
Today's Range$1.21 - $1.25
52-Week Range$0.45 - $3.12
Volume4,822 shs
Average Volume528,304 shs
Market Capitalization$25.38 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.81
Aemetis logoAemetis, Inc. operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol plant in the California Central Valley near Modesto; and a biodiesel plant in Kakinada, India. The company sells biodiesel and refined glycerin to resellers, distributors, and refiners through its sales force and independent sales agents, as well as to brokers who resell the product to end-users. It also produces ethanol; and wet distiller's grains, distiller's corn oil, and condensed distillers soluble or corn syrup products to dairies and feedlots as animal feed. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

Receive AMTX News and Ratings via Email

Sign-up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Industrial organic chemicals
Sub-IndustryN/A
SectorOils/Energy
SymbolNASDAQ:AMTX
CUSIPN/A
Phone408-517-3304

Debt

Debt-to-Equity Ratio-1.53
Current Ratio0.27
Quick Ratio0.11

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$150.15 million
Price / Sales0.16
Cash FlowN/A
Price / CashN/A
Book Value($4.03) per share
Price / Book-0.30

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-30,300,000.00
Net Margins-19.01%
Return on EquityN/A
Return on Assets-31.87%

Miscellaneous

Employees140
Outstanding Shares20,220,000
Market Cap$25.38 million

Aemetis (NASDAQ:AMTX) Frequently Asked Questions

What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

How were Aemetis' earnings last quarter?

Aemetis Inc (NASDAQ:AMTX) released its quarterly earnings data on Thursday, August, 9th. The specialty chemicals company reported ($0.27) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.34) by $0.07. View Aemetis' Earnings History.

When is Aemetis' next earnings date?

Aemetis is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Aemetis.

What price target have analysts set for AMTX?

3 analysts have issued 1-year price targets for Aemetis' stock. Their forecasts range from $2.00 to $2.00. On average, they expect Aemetis' stock price to reach $2.00 in the next twelve months. This suggests a possible upside of 65.3% from the stock's current price. View Analyst Price Targets for Aemetis.

What is the consensus analysts' recommendation for Aemetis?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Aemetis.

Who are some of Aemetis' key competitors?

Who are Aemetis' key executives?

Aemetis' management team includes the folowing people:
  • Mr. Eric A. McAfee, Co-Founder, Exec. Chairman, CEO & Pres (Age 55)
  • Mr. Todd A. Waltz, Exec. VP, CFO & Sec. (Age 57)
  • Mr. Andrew B. Foster, Exec. VP & COO (Age 53)
  • Mr. Sanjeev Gupta, EVP & Pres (Age 58)

Has Aemetis been receiving favorable news coverage?

Headlines about AMTX stock have been trending somewhat positive on Saturday, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aemetis earned a daily sentiment score of 0.10 on Accern's scale. They also assigned media headlines about the specialty chemicals company an impact score of 46.69 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View Recent Headlines for Aemetis.

How do I buy shares of Aemetis?

Shares of AMTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aemetis' stock price today?

One share of AMTX stock can currently be purchased for approximately $1.21.

How big of a company is Aemetis?

Aemetis has a market capitalization of $25.38 million and generates $150.15 million in revenue each year. Aemetis employs 140 workers across the globe.

How can I contact Aemetis?

Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company can be reached via phone at 408-517-3304 or via email at [email protected]


MarketBeat Community Rating for Aemetis (NASDAQ AMTX)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  74 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote "Outperform" if you believe AMTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.